Cargando…

Treatment of high-risk neuroblastoma

Although high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT) have improved the prognosis for patients with high-risk neuroblastoma (NB), event-free survival rates remain in the range of 30 to 40%, which is unsatisfactory. To further improve outcomes, several clinical trial...

Descripción completa

Detalles Bibliográficos
Autor principal: Sung, Ki Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346833/
https://www.ncbi.nlm.nih.gov/pubmed/22574071
http://dx.doi.org/10.3345/kjp.2012.55.4.115